Literature DB >> 3476943

Allelic variation in the DR subregion of the human major histocompatibility complex.

J I Bell, D Denney, L Foster, T Belt, J A Todd, H O McDevitt.   

Abstract

Allelic variation in the DR subregion of the human major histocompatibility complex has been analyzed by nucleic acid sequencing of cDNA clones obtained from cell lines homozygous by consanguinity for all the common serological types DR1-9. Two expressed loci were identified in the haplotypes DR2, -3, -4, -7, and -9; one locus being present at a much lower frequency (4-7%) than the other. The low-frequency allele was highly conserved between each of the DRw53 (DR4, -7, -9) and the DRw52 (DR3, -5, -6) haplotypes. Analysis of the variation between alleles confirms the presence of three allelic hypervariable regions. At each variable residue, a limited range of amino acid substitutions are found, distinguishing them from immunoglobulin hypervariable regions. Dinucleotide substitutions are extremely common. Individual hypervariable regions are often shared between haplotypes. Much of the variation in these alleles can be attributed to the shuffling of these regions between haplotypes, possibly by the mechanism of gene conversion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476943      PMCID: PMC299045          DOI: 10.1073/pnas.84.17.6234

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  DNA sequence and characterization of human class II major histocompatibility complex beta chains from the DR1 haplotype.

Authors:  J I Bell; P Estess; T St John; R Saiki; D L Watling; H A Erlich; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

3.  Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell line: genetic and evolutionary implications.

Authors:  J Moriuchi; T Moriuchi; J Silver
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

5.  Mapping SB in relation to HLA and GLO1 using cells from first-cousin marriage offspring.

Authors:  A Termijtelen; P Meera Khan; S Shaw; J J van Rood
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  An interactive graphics program for comparing and aligning nucleic acid and amino acid sequences.

Authors:  R Staden
Journal:  Nucleic Acids Res       Date:  1982-05-11       Impact factor: 16.971

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Cloning and sequence analysis of the human major histocompatibility complex gene DC-3 beta.

Authors:  J M Boss; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

9.  Mutations and selection in the generation of class II histocompatibility antigen polymorphism.

Authors:  K Gustafsson; K Wiman; E Emmoth; D Larhammar; J Böhme; J J Hyldig-Nielsen; H Ronne; P A Peterson; L Rask
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

10.  Serological and immunochemical analysis of the products of a single HLA DR-alpha and DR-beta chain gene expressed in a mouse cell line after DNA-mediated cotransformation reveals that the beta chain carries a known supertypic specificity.

Authors:  J Gorski; R Tosi; M Strubin; C Rabourdin-Combe; B Mach
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

View more
  58 in total

1.  Genomic polymorphism, recombination, and linkage disequilibrium in human major histocompatibility complex-encoded antigen-processing genes.

Authors:  P M van Endert; M T Lopez; S D Patel; J J Monaco; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

Review 2.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Nucleotide sequence of a novel HLA-DRB4B1 allele, DRB1*0409.

Authors:  J S Lanchbury; E E Jaeger; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

4.  Ten HLA-DR4 alleles defined by sequence polymorphisms within the DRB1 first domain.

Authors:  E W Petersdorf; A G Smith; E M Mickelson; P J Martin; J A Hansen
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

5.  Evolution of major histocompatibility complex class II allelic diversity: direct descent in mice and humans.

Authors:  A S Lundberg; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

6.  Molecular analysis of the MHC class II region in DR4, DR7, and DR9 haplotypes.

Authors:  E Kendall; J A Todd; R D Campbell
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

7.  Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

8.  Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.

Authors:  K Yamagata; H Nakajima; T Hanafusa; T Noguchi; A Miyazaki; J Miyagawa; M Sada; H Amemiya; T Tanaka; N Kono
Journal:  Diabetologia       Date:  1989-10       Impact factor: 10.122

9.  Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis.

Authors:  K Y Yuen; K S Chan; C M Chan; B S Ho; L K Dai; P Y Chau; M H Ng
Journal:  J Clin Pathol       Date:  1993-04       Impact factor: 3.411

10.  P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

Authors:  J Yeargin; J Cheng; A L Yu; R Gjerset; M Bogart; M Haas
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.